Optibiotix Health Share Discussion Threads

[mouse20] 23/5/2018 12:21

Risky, what do you think Gofigure sales were for a full year?
Also is It a typo to say month and years ahead? If so a potentially very mis-leading typo. If not then great!

[rayrac] 23/5/2018 12:17

“they've shipped some decent weight this year and I'm sure there will have been license fees paid on some of the deals.”

They’d let the market know if they had. Strapped for cash, no doubt about that. But they might have a friend? Sahara desert comes too mind.

[riskybusiness1] 23/5/2018 12:16

About what is expected from results today. We know revenues are only from a few orders from HLH and Go figure alone. Last years revenues came directly from DSM to carry out the LGG Work rather than product sales which are now building. We know around £700k of the costs are from SBTX Ipo alone which is now a current asset worth around £6m to Opti. The expenses also take in group losses which has no impact on Optis cash standing whatsoever. £1.25m in bank from Nov is about right. At the higher end of operating costs of £100kpm (even tho soh has stated they usually are around £65k with a £20k variable each month) Opti have over a year left in cash if they didn't get a single sale all year. We know these are building from multiple deals with higher value deals coming online since Nov. Seed has the backing to put us in profit on its own. Someone also mentioned warrants too that have been exercised since, from memory roughly around £200k and you'll also have tax credits too which will be added to current cash balance.All in all as SOH stated many times before no need for a placement whatsoever to carry out existing plans through to profitability later this year. If they desperately needed cash they could sell some SBTX which will probably be in the 25p - 30p range soon if they complete clinical trials successfully. Below I believe are some of the most significant pieces in results:'In April 2017, OptiBiotix's majority owned skincare subsidiary, SkinBiotherapeutics (formerly SkinBiotix), was admitted to AIM with an associated £4.5m fundraise, supported by institutional investors. This is part of OptiBiotix's strategy of building value in each of its divisions with some of this value, when realised, being returned to shareholders and reinvesting some of the gains to develop other divisions so they, in due course, can become separate legal entities with the potential for a separate public listing.The deal announced with Akums in May 2018 is an early example of such a deal whereby the partner provides all funding for drug registration, phase 3 and 4 clinical studies, in return for exclusivity and royalty payments based on future product sales. We anticipate future high value deals for use of  LPLDL® as a biotherapeutic in other territories in the month and years ahead.We believe the Company has now significantly de-risked scientific, clinical and manufacturing risk across its platforms. This changes the risk reward ratio leading to an increase in value and the Company and its assets becoming an attractive proposition for corporate partners. This has led to a number of approaches from potential acquirers interested in assets in specific divisions.'

[rayrac] 23/5/2018 12:07

“they've shipped some decent weight this year and I'm sure there will have been license fees paid on some of the deals.“

Don’t worry, if they had a sniff of a licence deal with cash attached, they would have let the market know!

Strapped is my reading of the situation.

[rafboy] 23/5/2018 11:50

Yes, it looks like it. Be good to hear what SOH has to say.

[rathean] 23/5/2018 10:04

Interesting reversal in share price behaviour, previous resistance to good news now support for meh news. Was hoping to double up at a lower price but maybe the potential baked in now is enough to sustain the current share price levels?

[monkeywench1] 23/5/2018 09:58

Lol I have never known a chilled ramper.

[shrewdmole] 23/5/2018 09:45

pglancy,

technical error. I phone said it hadn't posted it!!

im chilled don't worry.

s

[michaelmouse] 23/5/2018 09:37

Two simple questions that they should have addressed:-

1) How much cash is left?

2) What were revenues from December 2017 - May 2018?

Not difficult to answer, but stony silence from the company.

Tells its own story.

Aimho.

[pglancy] 23/5/2018 09:27

Shrewd you need to chill. Same post 16 mins later.

[shrewdmole] 23/5/2018 09:17

Guys theyve shipped some decent weight this year and I'm sure there will have been license fees paid on some of the deals.

Seed will hit the shelves very quickly then there's Tata and galenicum this year.

Soh obviously isnt concerned and he's the biggest private shareholder.

[pglancy] 23/5/2018 09:14

elrico explained the increased losses and cash burn to 2 events when he was explaining these to MM some time ago. I can't find the post. I remember his saying increased losses were not a cash loss they were a result of ip transfer to sbtx and the increased admin was the cost of the sbtx ipo. Todays cash looks in line with what we already know.

[shazbo] 23/5/2018 09:01

I knew we wouldn’t get figures but I thought he might throw us a bone with a more bullish forward looking statement. Damp squib.

[shrewdmole] 23/5/2018 08:58

Guys theyve shipped some decent weight this year and I'm sure there will have been license fees paid on some of the deals.

Seed will hit the shelves very quickly then there's Tata and galenicum this year.

Soh obviously isnt concerned and he's the biggest private shareholder.

[bobalot] 23/5/2018 08:49

Didn't the company cash in some warrants; if they did the cash position will be better than published since last November.However the business is developing very well imo.

[zebbo] 23/5/2018 08:36

Finances looking strong, looks like some people cannot do the maths. Agree with belgrano2. With zero income we still have 12 months funding

Not even a topic worthy of discussion

[2350220] 23/5/2018 08:32

I've added to my Spreadex December spreadbet this morning.
Unfortunately, their spread is really wide at about 3p.
So I'm quite underwater with all these Spreadbets at the moment.
John

[monkeywench1] 23/5/2018 08:32

I think the Rampers will be very busy for at least 6 months.

[belgrano2] 23/5/2018 08:28

Still 1.25 in the bank, should see this year out even with zero income. Company still being shrewd with expenditure which is a great positive. No unpleasantries that we’ve seen it this runs, about last years revenue.

[tsmith2] 23/5/2018 08:28

Placing ahoy!Rampety ramp

[smarner] 23/5/2018 08:26

A lot has happened since November!

[loungeact] 23/5/2018 08:26

I always go around posting on forums about shares that I would never invest in, it’s what I like to do first thing in the morning, because i’m a big loser in life - Rayrac.

[speccy1] 23/5/2018 08:25

Some have mentioned increased cash burn this morning. Don't forget a significant chunk of that was the cost of spinning off SBTX, which generated a decent increase in assets.

We may have similar costs this year to float Sweetbiotix, but with a similar increase in assets.

My only concern is the cost of returning those assets to shareholders at this stage may delay any free shares or dividends until there's enough income to ensure break-even. Here for long term so willing to wait.

[vanduke] 23/5/2018 08:24

Never held bioprogres.But an OPTI in progress.

[rayrac] 23/5/2018 08:22

Running out of cash, where’s it coming from. Another 6/12months waiting, so cash needed.

Wouldn’t touch.